AstraZeneca Anticipates Vaccine Efficacy Results by Year-End
ZURICH/FRANKFURT: AstraZeneca should still know before the end of the year whether its experimental vaccine protects people against COVID-19, the drugmaker’s chief executive Pascal Soriot said on Thursday, as long as it can resume trials soon. The British company suspended late-stage trials this week after an illness in a participant in Britain. The patient was […]
Continue Reading